Peru Decentralized HIV Care
Innovations in Decentralizing HIV Services in Peru
2 other identifiers
interventional
1,450
2 countries
2
Brief Summary
The purpose of this study is to understand the processes by which HIV care is decentralized, an evidence-informed strategy to improve retention in HIV care, in Peru. Decentralization of HIV services has not been evaluated using experimental designs and urban decentralization studies of HIV are uncommon, so this study will lend important insights for future decentralization efforts in Peru and other countries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started Apr 2024
Longer than P75 for not_applicable hiv
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2023
CompletedFirst Posted
Study publicly available on registry
June 18, 2023
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
May 11, 2025
May 1, 2025
4.3 years
June 7, 2023
May 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of diagnosed PWH in treatment in PHC within the district
The percentage of diagnosed PWH in treatment in PHC within the district will be used to assess the extent to which decentralized services are adopted and scaled-up in PHCs. Higher percentage indicates more services adopted and scaled-up.
up to month 54
Secondary Outcomes (1)
Effectiveness assessed as the extent of RIC and VS within the district
up to month 54
Study Arms (3)
Group 1
EXPERIMENTALControl (month 7-12) then NIATx+ECHO (month 13-36) then Maintenance (month 37-54)
Group 2
EXPERIMENTALControl (month 7-18) then NIATx+ECHO (month 19-42) then Maintenance (month 43-54)
Group 3
EXPERIMENTALControl (month 7-24 then NIATx+ECHO (month 25-48) then Maintenance (month 49-54)
Interventions
Project ECHO will be combined with NIATx to provide clinical skills to PHC staff and delivered in a hub and spoke model to connect SHC and PHC staff in delivery of HIV care. Decentralization will occur through guideline concordance, facilitated through NIATx and ECHO.
Eligibility Criteria
You may qualify if:
- Survey of PHC and SHC Clinicians (N=330):
- Currently employed at a PHC or SHC that is participating in the study. Provide consent for participation.
- Continuing Professional Development (N=825):
- Currently employed as a nurse or physician who fulfilled the ECHO training requirements
- Survey of PHC Leadership (N=165):
- Currently serving as the leader of a PHC.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Yale University
New Haven, Connecticut, 06520, United States
CITBM - Centro de Investigaciones Tecnológicas Biomédicas y Medioambientales
Bellavista, 07006, Peru
Study Officials
- PRINCIPAL INVESTIGATOR
Frederick Altice, M.D., M.A.
Yale University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2023
First Posted
June 18, 2023
Study Start
April 1, 2024
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
May 11, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share